Prevalence of adult-onset IDDM in the U.S. population

Diabetes Care

Volumn 17, Issue 11, 1994, Pages 1337-1340

  Harris, Maureen I ^a   Robbins, David C ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Medlantic Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; OBESITY; PREVALENCE; UNITED STATES;

EID: 0028104610     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.17.11.1337     Document Type: Article

References (26)

1. Libman I, Songer T, LaPorte R: How many people in the U.S. have IDDM? Diabetes Care 16:841-842, 1993
2. Melton LJ, Palumbo PJ, Chu CP: Incidence of diabetes mellitus by clinical type. Diabetes Care 6:75-81, 1983
3. Melton LJ, Ochi JW, Palumbo PJ, Chu CP: Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes Care 6:427-431, 1983
4. Laakso M, Pyorala K: Age of onset and type of diabetes. Diabetes Care 8:114-117, 1985
5. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36:523-534, 1987
6. McDowell A, Engle A, Massey JT, Maurer K: Plan and Operation of the Second National Health and Nutrition Examination Survey 1976-80. NCHS Vital and Health Statistics, Ser. 1, no. 15. Washington, DC, U.S. Govt. Printing Office, 1981 (DHHS publ. no. PHS-81-1317)
7. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
8. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
9. Irvine WJ, McCallum CJ, Gray RS, Campbell GJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ: Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, co-existent autoimmune disease, and HLA type. Diabetes 26:138-147, 1977
10. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M: A comparison of childhood and adult type I diabetes mellitus. New Engl J Med 320:881-886, 1989
11. Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving HH, Deckert T, Molsted-Pedersen L, Kohl C, Buschard K, Green A: HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28: 237-244, 1986
12. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transbol J, Binder C: Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210:153-156, 1981
13. Wilson BM, Van der Minne P, Deverill J, Heller SR, Getsthope K, Reevers WG, Tattersall RB: Insulin dependence: problems with the classification of 100 consecutive patients. Diabetic Med 2:167-172, 1985
14. Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241, 1986
15. Groop LC, Miettinen A, Groop P-H, Meri S, Koskimies S, Bottazzo GF: Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes. Diabetes 37: 99-103, 1988
16. Diabetes Control and Complications Trial Research Group: Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 11:567-573, 1988
17. Niskanen LK, Uusitupa MI, Sarlund H, Siitonen O, Pyorala K: Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Diabetes Care 13: 41-48, 1990
18. Laakso M, Sarlund H, Pyorala K: Prevalence of insulin deficiency among initially non-insulin-dependent middle-aged diabetic individuals. Diabetes Care 9:228-231, 1986
19. Bushhouse SA, Goetz FC, Jacobs DR, Bender AP, French LR, Oestreich PG, Geisser MS: C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota. Diabetes Care 15:1335-1347, 1992
20. Laakso M, Sarlund H, Pyorala K: Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics. Diabetes Res 4:95-99, 1987
21. Landin-Olsson M, Nilsson KO, Lemmark A, Sundkvist G: Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561-568, 1990
22. Gjessing HJ, Matzen LE, Faber OK, Proland A: Fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32:305-311, 1989
23. Katzeff HL, Savage PJ, Barclay-White B, Nagulesparan M, Bennett PH: C-peptide measurement in the differentiation of type I (insulin-dependent) diabetes mellitus. Diabetologia 28:264-268, 1985
24. Madsbad S: Classification of diabetes in older adults. Diabetes Care 13 (Suppl. 2): 93-96, 1990
25. American Diabetes Association: Physician's Guide to Insulin-Dependent (Type I) Diabetes: Diagnosis and Treatment. Alexandria, VA, American Diabetes Association, 1988
26. American Diabetes Association: Physician's Guide to Non-Insulin-Dependent (Type II) Diabetes: Diagnosis and Treatment. Alexandria, VA, American Diabetes Association, 1988